The HDL receptor, scavenger receptor class B type I (SR-BI), is expressed on the surface of multiple cell types and has been shown to mediate both HDL-dependent atheroprotective © 2014 American Heart Association, Inc.
A therosclerosis is a chronic inflammatory disease driven by complex interactions between circulating lipoproteins, immune cells, and the cells of the artery wall. 1 Atherosclerotic coronary artery disease (CAD) is a leading cause of death worldwide, and hypercholesterolemia is a major risk factor. 1 High levels of cholesterol circulating in low and very low-density lipoproteins (LDL and VLDL, respectively) are major risk factors for atherosclerosis, whereas high levels of high-density lipoproteins (HDLs) are considered to be atheroprotective. 2 Traditional murine models of atherosclerosis are genetically predisposed to hypercholesterolemia and include the apolipoprotein E (apoE) knockout mouse 3, 4 and the fat-fed LDL receptor (LDLR) knockout mouse. 5, 6 The aortic sinus, the lesser curvature of the aortic arch, and other regions of large arteries where blood flow is nonlaminar are robustly susceptible to the development of atherosclerotic plaques in these mouse models. 7 However, coronary arteries (CAs), the arteries that supply blood to the heart, remain largely resistant to atherosclerosis. 7 These mice, therefore, do not present with many of the clinical complications of atherosclerosis experienced by human CAD patients, including myocardial infarction and early death. signaling 8, 9 and selective lipid transfer between HDL and cells, which is critical for functional reverse cholesterol transport, the major avenue for cholesterol removal from peripheral tissues. 8, 10 Deficiency of SR-BI not only accelerates atherosclerosis in the aortic sinus of apoE knockout mice 11 but also renders these mice susceptible to spontaneous occlusive CA atherosclerosis, myocardial infarction, and ultimately early death. 12 A related model, the SR-BI knockout/apoE hypomorphic mouse, develops a similar phenotype when fed high fat, high cholesterol (HFC) diets. 13, 14 We have previously shown that SR-BI deficiency increases atherosclerosis in the aortas of LDLR knockout mice fed a high-fat (HF) Western-type diet; however, reduced survival was not observed in these mice, and CA atherosclerosis was not assessed. 15 In the current study, we tested the effects of feeding SR-BI/ LDLR double knockout (dKO) mice 4 different atherogenic diets with varying concentrations of fat, cholesterol, and sodium cholate. We found that dKO mice developed extensive occlusive CA atherosclerosis when fed any of the 4 diets that we tested, whereas CAs from control LDLR knockout mice fed the same diets were virtually free of plaque. This was accompanied by robust myocardial infarction and reduced survival in dKO mice fed diets with very high cholesterol (HC) content, but not in mice fed the high fat, low cholesterol Western-type diet. The severity of the survival phenotype appeared to correlate with the abundance of CA plaques that showed evidence of platelet accumulation. We also show that dKO mice exhibit monocytosis and increased diet-induced systemic inflammation compared with LDLR knockout control mice, likely contributing to the increased overall atherosclerosis in dKO mice. Finally, we demonstrate that CA endothelium in atherogenic diet-fed dKO mice expresses higher levels of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) than that of control LDLR knockout mice. This explains the relative susceptibility of SR-BI-deficient mice to developing atherosclerosis in their CAs. The SR-BI/LDLR dKO mouse is, therefore, a novel model of diet-inducible CA atherothrombosis.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Survival of SR-BI/LDLR dKO Mice Fed Different Atherogenic Diets
We studied the effects of 4 different atherogenic diets with varying levels of fat, cholesterol, and sodium cholate on the progression of atherosclerosis in SR-BI/LDLR dKO and control LDLR knockout mice. Mice were fed a HF diet (Western-type diet; 22% fat, 0.15% cholesterol), a HC diet (2% cholesterol), a HFC diet (15.8% fat, 1.25% cholesterol), or the same diet containing sodium cholate (high fat, high cholesterol, cholate [HFCC] diet, commonly referred to as the Paigen diet). 16 As controls, dKO and LDLR knockout mice were also fed a normal chow diet. The dKO mice fed the HFCC, HFC, and HC diets but not those fed the HF diet ≤12 weeks exhibited reduced survival compared with LDLR knockout mice fed the same diets ( Figure 1A-1D ). Average survival for dKO mice fed the HFCC, HFC, and HC diets was 3.5, 9.4, and 11.4 weeks, respectively. No dKO mice fed the HFCC diet survived >4.5 weeks of feeding, whereas ≈7% of mice fed the HFC diet and ≈64% of mice fed the HC diet lived the full 12 weeks. Neither dKO mice nor LDLR knockout control mice fed normal chow diets exhibited any reductions in survival during the course of our studies. These survival trends are similar to those reported by Nakagawa-Toyama et al 14 in SR-BI knockout/apoE hypomorphic mice when fed the HFCC, HFC, and HF diets. Figure 1E to 1L shows images representing aortic sinus plaque burden in control LDLR knockout mice ( Figure 1E-1H ) and dKO mice ( Figure 1I-1L) fed each of the atherogenic diets. Aortic sinus plaque size was analyzed after 12 weeks of feeding the HF or HC diets and at 10 weeks of feeding the HFC diet or 3.5 weeks of feeding the HFCC diet. These times were chosen to correspond to the length of time for ≈50% survival of the dKO mice on the respective diets. Although longer feeding periods generally resulted in larger plaques, aortic sinus plaque area was dramatically and significantly increased in dKO mice fed any of the 4 diets that we tested compared with control LDLR knockout mice fed the same diet for the same length of time ( Figure 1M-1P) . dKO mice fed a normal chow diet and age-matched to HF-and HC-fed mice (22 weeks old) also developed substantially more atherosclerosis in their aortic sinuses compared with age-matched LDLR knockout mice ( Figure IA -IC in the online-only Data Supplement). The extent of atherosclerosis in normal chow-fed dKO mice was much less than similarly aged dKO mice that had been fed either the HF or HC diet for 12 weeks (compare Figure IB and IC in the online-only Data Supplement with Figure 1I , 1J and 1M, 1N), but was similar to the level of atherosclerosis in the aortic sinus of younger dKO mice that had been fed the HFCC diet for 3.5 weeks ( Figure 1L and 1P).
Atherosclerosis in the Aortic Sinus
Atherosclerosis in CAs
CA atherosclerosis was measured by scoring all CAs observed in at least 3 oil red O-stained cross-sections into 5 categories based on the level of occlusion. Representative images of CAs that were plaque-free, which contained fatty streaks, or which were <50% occluded, >50% occluded, and 100% occluded with raised atherosclerotic plaques are shown in Figure 2A to 2E. All SR-BI/LDLR dKO mice developed occlusive CA atherosclerosis when fed any of the 4 atherogenic diets ( Figure 2F-2I ). SR-BI/LDLR dKO mice had significantly greater proportions of CAs with all categories of atherosclerotic plaques and correspondingly significantly smaller proportions of CAs that were plaque-free compared with control LDLR knockout mice fed the same diets for similar time periods. In fact, >95% of CAs observed in all LDLR knockout control groups, regardless of atherogenic diet, were either plaque-free or contained only fatty streaks. In contrast, <60% of CAs from SR-BI/LDLR dKO mice were either plaque-free or contained only fatty streaks, regardless of the atherogenic diet. SR-BI/LDLR dKO mice fed the HF diet for 12 weeks exhibited the lowest proportion of completely occluded CAs (18%), whereas the SR-BI/LDLR dKO mice fed the HC (12 weeks), HFC (10 weeks), or HFCC diet (3.5 weeks) had similarly high proportions with ≈30% of CAs completely occluded. Interestingly, the CA atherosclerosis burden did not seem to correlate directly with the atherosclerotic plaque sizes in the aortic sinus in SR-BI/LDLR dKO mice fed the 4 atherogenic diets. In particular, dKO mice fed the HFCC diet for 3.5 weeks had the lowest burden of aortic sinus atherosclerosis ( Figure 1P ) but among the highest burden of CA atherosclerosis ( Figure 2I ). In contrast, chow-fed dKO mice developed comparatively little CA atherosclerosis by 22 weeks of age ( Figure IE in the online-only Data Supplement). An important feature of human coronary heart disease is acute thrombosis on top of atherosclerotic plaques in CAs. We, therefore, looked for molecular evidence of thrombosis in dKO mice fed atherogenic diets. Thrombosis was detected in cryosections of CAs by immunofluorescence for CD41, a surface protein expressed by platelets. Figure 2J absence of atherosclerotic plaques. On the contrary, platelet CD41 was detected in CA plaques from dKO mice fed each of the 4 atherogenic diets ( Figure 2R -2U). Interestingly, both the abundance of platelet staining ( Figure 2N -2Q) and the number of CAs per section that stained positively for platelet CD41 ( Figure 2R -2U) were substantially higher in the SR-BI/ LDLR dKO mice fed the HFCC diet than for those fed other atherogenic diets.
Myocardial Infarction
Frozen cross-sections of myocardial tissue were stained with Masson trichrome to detect collagen-rich fibrotic areas.
Representative images are shown in Figure 3A to 3H. SR-BI/ LDLR dKO mice fed the HFCC, HFC, and HC diets had similar levels of myocardial fibrosis, which were substantially and significantly higher than levels observed in HF-fed dKO mice ( Figure 3I -3L). No fibrosis was detected in any LDLR knockout control mice regardless of diet ( Figure 3I -3L) or in dKO mice fed a normal chow diet ≤22 weeks of age ( Figure  IF and IG in the online-only Data Supplement). Similarly, we observed no differences in heart to body weight ratio between dKO and LDLR knockout mice fed the normal chow diets. Heart to body weight ratios were significantly increased to a similar extent in all atherogenic diet-fed dKO groups compared with LDLR knockout control mice fed the same diets for similar periods of time ( Figure 3M-3P increased heart size is likely not a direct response to myocardial fibrosis.
Plasma Lipoproteins and Cytokines
To investigate potential mechanisms underlying the increased susceptibility to atherosclerosis in the aortic sinus and CAs observed in dKO mice compared with control LDLR knockout mice, we analyzed plasma lipid levels and lipoprotein cholesterol profiles from mice fed the 4 atherogenic diets and the normal chow diet. Consistent with previous reports, 15 plasma total cholesterol was 1.5-fold higher in the chow-fed dKO than the chow-fed LDLR knockout mice (Table I in the online-only Data Supplement), mainly because of increased cholesterol associated with enlarged HDL particles ( Figure  ID in the online-only Data Supplement). As expected, plasma total cholesterol levels were substantially elevated in both dKO and in LDLR single knockout mice when they were fed each of the 4 atherogenic diets (Table I in the online-only Data Supplement). Consistent with our previous findings, 15 dKO mice fed atherogenic diets consistently had lower plasma total cholesterol levels compared with LDLR single knockout mice fed the same diet (Table I in the online-only Data Supplement). This appeared to be the result of lower total cholesterol associated with VLDL and LDL in the atherogenic diet-fed dKO mouse plasma compared with plasma from LDLR knockout control mice across all 4 atherogenic diets tested ( Figure 4A-4D ), indicating that plasma VLDL and LDL cholesterol levels are likely not responsible for the increased atherosclerosis observed in SR-BI/LDLR dKO mice. Lower steady-state VLDL and LDL total cholesterol levels in atherogenic diet-fed dKO compared with LDLR knockout mice may be explained by the lower rates of hepatic VLDL synthesis and triglyceride secretion, measured using standard methodologies in either HFCC-or HF-fed dKO or LDLR knockout mice that had been fasted and treated with either tyloxapol or poloxamer 17 ( Figure II in the online-only Data Supplement). This is consistent with our previous reports of reduced plasma apoB levels in HF-fed SR-BI/LDLR dKO mice and in chowfed SR-BI/apoE dKO mice. 11, 15 Despite the reduced levels of plasma total cholesterol in atherogenic diet-fed dKO mice, we observed elevated levels of plasma-free cholesterol in the dKO compared with the LDLR knockout mice fed the control diet and each of the 4 atherogenic diets, such that the ratios of free to total cholesterol were consistently 2-to 3-fold higher in the normal chow and atherogenic diet-fed dKO mice than the LDLR knockout controls. This is consistent with increased free cholesterol levels that have been described previously in SR-BI-deficient mice. 13, 18, 19 Because inflammation is also a major driver of atherosclerosis, we measured interleukin-6 (IL-6) and tumor necrosis factor-α (TNFα) in plasma from these mice. IL-6 and TNFα were undetectable in LDLR knockout or dKO mice fed normal chow ≤22 weeks of age (data not shown). Each of the 4 atherogenic diets resulted in significantly increased levels of both IL-6 ( Figure 4E-4H ) and TNF-α ( Figure 4I-4L ) in both the LDLR knockout and the dKO mice; however, plasma levels of each cytokine were consistently higher in dKO than in LDLR knockout mice fed the same diet. We also noted that plasma levels of IL-6 and TNFα were higher in dKO mice fed the HFCC, HFC, and HC diets compared with dKO mice fed the HF diet, suggesting that they may have been influenced by dietary cholesterol and cholate. 
Blood Cells
Because immune cells are major components of atherosclerotic plaques and can also influence levels of inflammatory cytokines in the plasma, we ran hematology profiles, including monocyte and lymphocyte counts, on the blood of HFCC-fed mice. Circulating monocytes and lymphocytes were both significantly elevated in dKO mice compared with control LDLR knockout mice fed either normal chow ( Figure IH and II in the online-only Data Supplement) or after 2 weeks of HFCC feeding ( Figure 5A and 5B). Monocytes (CD11b and CD115 double-positive cells) were analyzed for Ly6C expression using flow cytometry. Three distinct populations of monocytes were identified ( Figure 5C . dKO mice also exhibited substantially and significantly larger spleens than control LDLR knockout mice, which were further increased in size on atherogenic diet feeding (Table II in the online-only Data Supplement). HFCC-fed dKO mice also exhibited significantly fewer red blood cells, accompanied by lower hematocrits and a higher mean cell volume compared with control LDLR knockout mice fed the same diet (Table III in the online-only Data Supplement), consistent with published findings in HC-fed SR-BI knockout mice and in SR-BI/apoE dKO mice. 20 No significant differences in platelet numbers were observed between the 2 groups of mice (Table III in 
CA Endothelial Cell Activation
To further investigate the robust susceptibility of SR-BI/ LDLR dKO mice to CA atherosclerosis, we investigated the expression of VCAM-1 and ICAM-1 in the CAs of both control LDLR knockout and dKO mice by immunofluorescence. Figure 6A to 6D depicts representative images of VCAM-1 and ICAM-1 staining in nonatherosclerotic CAs from HFCC-fed LDLR knockout and dKO mice. Quantification of VCAM-1 and ICAM-1 immunostaining in nonatherosclerotic CAs from mice fed each of the 4 atherogenic diets revealed that atherogenic diet-fed dKO mice had significantly greater proportions of nonatherosclerotic CAs exhibiting immunodetectable VCAM-1 ( Figure 6E-6H ) and ICAM-1 ( Figure 6I -6L) compared with control LDLR knockout mice fed the same diets for similar times. In contrast, no differences were seen in VCAM-1 or ICAM-1 levels in LDLR knockout mice fed either the atherogenic diets or fed a normal diet ≤22 weeks of age, and no differences were seen between the chow-fed 22-week-old dKO and LDLR knockout mice ( Figure IM -IR in the online-only Data Supplement). These data demonstrate that each of the 4 atherogenic diets tested induces significant VCAM-1 and ICAM-1 expression in nonatherosclerotic CAs only in the dKO mice.
Discussion
In this study, we demonstrated that SR-BI/LDLR dKO mice develop diet-accelerated occlusive CA atherosclerosis and myocardial infarction, in which the severity of the disease can be modulated by altering different components of the diet. We have previously shown that dKO mice develop increased aortic atherosclerosis compared with control LDLR knockout mice when fed a HF diet; however, there was no difference in survival, and the study did not examine atherosclerosis in CAs. 15 Consistent with our previous findings, dKO mice fed the HF diet for 12 weeks did not exhibit reduced survival but had significantly increased aortic sinus atherosclerosis compared with LDLR knockout controls (Figure 1 ). Occlusive CA atherosclerosis was observed in these mice ( Figure 2) ; however, only small myocardial infarctions were detected (Figure 3 ). In contrast, higher levels of occlusive CA atherosclerosis developed in dKO mice fed diets much higher in cholesterol ( Figure 2 ). This was accompanied by large myocardial infarctions ( Figure 3 ) and significantly reduced survival ( we tested developed virtually no CAD ≤12 weeks of feeding. We also showed that aggregated platelets are present in a subset of occluded CAs in the dKO mice, and that platelet staining is most prominent in CAs of dKO mice fed the HFCC diet (Figure 2) , which led to the most rapid development of myocardial infarction (Figure 3 ) and the earliest death of dKO mice (Figure 1 ). These data suggest that the nature of the atherogenic diet affects not only the extent and time course of development of CA atherosclerosis but also affects the severity of platelet accumulation within plaques, possibly reflecting plaque rupture and thrombosis.
Deficiency of SR-BI increases cholesterol associated with enlarged HDL particles in otherwise wild-type mice and in LDLR knockout mice fed normal chow ( Figure ID in the online-only Data Supplement), 21, 22 and in VLDL and intermediate density lipoprotein/LDL in apoE knockout mice fed normal chow and apoE hypomorphic mice fed the HFCC diet. 11, 13 In contrast, SR-BI/LDLR dKO mice have lower cholesterol levels associated with VLDL and LDL compared with LDLR knockout mice on all 4 of the atherogenic diets. This is consistent with our previous reports of reduced cholesterol associated with VLDL and reduced plasma apoB in SR-BI/ LDLR dKO mice compared with LDLR knockout mice when both were fed the HF diet, 15 and with the reduced apoB levels observed in SR-BI/apoE dKO mice compared with apoE single knockout controls. 11 In the HF or HC-fed SR-BI/LDLR dKO mice, this seems to be a consequence of reduced VLDL production as compared with similarly fed LDLR knockout control mice ( Figure II in the online-only Data Supplement). The mechanism of reduced VLDL production in dKO mice is not clear; however, SR-BI overexpression has been shown to enhance apoB trafficking and apoB secretion 23 in Caco-2 cells, whereas loss of SR-BI function and knockdown of SR-BI 23 blunts apoB trafficking and secretion, respectively. SR-BI may have an equivalent role in hepatocytes. A similar reduction in VLDL levels has also been reported in LDLR knockout mice that lack apolipoprotein A1, 24 the major apolipoprotein of HDL. Additionally, apolipoprotein A1 deficiency has been linked with reduced hepatic VLDL production in mice, 25 suggesting that interaction between SR-BI and its major ligand may be responsible for influencing the production of VLDL; further experiments are required to confirm this. It is possible that this effect of a lack SR-BI on VLDL production is an antiatherogrenic effect that is masked by more severe proatherogenic forces, yet it is also possible that this represents as a consequence of a fundamental disruption in VLDL metabolism, resulting in promotion of atherosclerosis. Nevertheless, in this context, increased atherosclerosis is associated with lower overall and VLDL cholesterol levels, and this observation suggests that the susceptibility of SR-BI/ LDLR dKO mice to CAD cannot be explained by exacerbated hypercholesterolemia, although the disproportionately large ratio of free cholesterol to total cholesterol (Table I in the online-only Data Supplement) indicates there is likely a major effect on lipoprotein composition, which could, in turn, affect CAD susceptibility. The influence of a lack of SR-BI on the composition and function of different lipoproteins in these mice requires further investigation.
There is mounting evidence that SR-BI may play an atheroprotective role in immune cells. Bone marrow-specific deficiency of SR-BI in both apoE knockout and LDLR knockout mice increases atherosclerosis in the aorta. 15, 26, 27 Conversely, we have recently shown that restoring SR-BI expression in the bone marrow of SR-BI knockout/apoE hypomorphic mice reduces diet-induced occlusive CA atherosclerosis, whereas others have shown that transplanting SR-BI/apoE dKO mice with wild-type bone marrow has a similar effect.
28,29 SR-BI in macrophages reduces the inflammatory response to lipopolysaccharide treatment in vitro, 30 and SR-BI deficiency is associated with higher serum cytokine levels in naïve, septic, and lipopolysaccharide-challenged mice. [31] [32] [33] Results from the current study show that SR-BI/LDLR dKO mice challenged with atherogenic diets have increased levels of both IL-6 and TNFα in plasma, accompanied by increased numbers of both monocytes and lymphocytes in blood compared with LDLR knockout mice fed the same diets. We have previously demonstrated that monocyte recruitment into atherosclerotic plaques is attenuated by restoration of SR-BI expression in the bone marrow of SR-BI knockout/apoE hypomorphic mice, and that SR-BI-deficient monocytes bind VCAM-1 and ICAM-1 more readily than SR-BI-expressing monocytes. 29 Monocytes can be divided into subsets based on their level of Ly6C expression. Ly6C hi monocytes are considered to be more inflammatory, adhere more efficiently to activated endothelium, migrate more efficiently into established atherosclerotic plaques, and selectively accumulate in atherosclerotic plaques compared with Ly6C lo monocytes. 34, 35 We observed a large shift in the monocyte populations with HFCC-fed dKO mice exhibiting significantly higher proportions of Ly6C hi and Ly6C int monocytes and correspondingly lower proportions Ly6C lo monocytes compared with LDLR knockout control mice fed similar diets.
Although increased inflammation and altered lipoprotein metabolism may explain an increase in susceptibility to atherosclerosis in general, the robust dichotomy between the SR-BI/LDLR dKO mice and the LDLR knockout controls in terms of CA atherosclerosis suggests that SR-BI may influence the susceptibility of the vessels themselves. A major factor that dictates the regions of the vascular system that are prone to atherosclerosis is the activation of endothelial cells. 36 Endothelial cells from arterial regions that experience laminar flow conditions express very low levels of VCAM-1 and ICAM-1, and these arteries tend to be resistant to atherosclerosis. 37, 38 Alternatively, endothelial cells from arterial regions that experience nonlaminar blood flow and low shear stress exhibit reduced endothelial nitric oxide synthase expression and activation 9 and increased expression of adhesion molecules VCAM-1 and ICAM-1. 37, 38 This provides favorable sites for monocyte adhesion and initiation of atherosclerosis. 36 SR-BI mediates HDL-induced upregulation and activation of eNOS in vivo and concomitant suppression of VCAM-1 and ICAM-1 expression by endothelial cells in vitro. [40] [41] [42] Our results provide in vivo evidence that endothelial cells in nonatherosclerotic CAs of dKO mice fed atherogenic diets express more VCAM-1 and ICAM-1 compared with CA endothelial cells in LDLR knockout control mice. This may at least in part explain why SR-BI deficiency in LDLR knockout mice gives rise to diet-induced CA atherosclerosis, whereas LDLR single knockout mice seem to be largely resistant. A limitation of study is that it is difficult to determine if the Ly6C hi monocytosis, inflammation, and upregulated VCAM-1 and ICAM-1 expression in CA endothelial cells precede development of CAD, or if they are consequences of enhanced lesion development. Further investigation will be required to conclude that these are causative factors of CAD in these mice.
In summary, SR-BI/LDLR dKO mice are a robust and flexible mouse model of diet-accelerated occlusive CA atherothrombosis and myocardial infarction, which could prove to be a useful tool in understanding the mechanisms of and exploring new treatments for human coronary heart disease. We think that mouse CAD resulting from SR-BI deficiency is a multifactorial phenomenon that may be influenced by a lack of SR-BI function in multiple cell types, including hepatocytes, immune cells, and endothelial cells. In particular, the increased expression of endothelial cell adhesion molecules in CAs, together with the increased proportions of circulating Ly6C hi monocytes, may conspire to trigger diet-induced occlusive CA atherosclerosis in these mice, which, depending on the atherogenic diet used, leads to substantial platelet accumulation in occluded CAs, myocardial infarction, and early death. The importance of specific protective roles of SR-BI in each of these cell types and characterization of the molecular pathways involved requires further investigation and may lead to the identification of new therapeutic targets in the treatments of cardiovascular diseases.
